PDF herunterladen
Semin intervent Radiol 2010; 27(3): 261-267
DOI: 10.1055/s-0030-1261784
© Thieme Medical Publishers

An Overview of Image-Guided Percutaneous Ablation of Renal Tumors

Majid Maybody1
  • 1Section of Interventional Radiology, Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
20. August 2010 (online)

Auch verfügbar auf
    Lizenzen und Reprints

ABSTRACT

Although nephron-sparing surgery remains the gold standard treatment for small renal tumors, minimally invasive image-guided percutaneous ablation is becoming a viable alternative to operative resection. Percutaneous radiofrequency ablation (RFA) and cryoablation show high technical success rates, a relatively low incidence of residual or recurrent tumor, and competitive rates of patient survival. In this review, an overview of the current status of image-guided percutaneous ablation of renal tumors is presented, with a focus on procedure indications and patient selection, technical aspects of ablation procedures, and treatment outcomes and patient follow-up.

KEYWORDS

Percutaneous - ablation - radiofrequency - cryoablation - kidney - renal - tumor

REFERENCES

  • 1 Chow W H, Devesa S S, Warren J L, Fraumeni Jr J F. Rising incidence of renal cell cancer in the United States.  JAMA. 1999;  281 1628-1631
    CrossrefPubMedGoogle Scholar
  • 2 Pantuck A J, Zisman A, Belldegrun A S. The changing natural history of renal cell carcinoma.  J Urol. 2001;  166 1611-1623
    CrossrefPubMedGoogle Scholar
  • 3 American Cancer Society .Cancer Statistics 2008. Atlanta, GA; American Cancer Society 2008
    PubMedGoogle Scholar
  • 4 Luciani L G, Cestari R, Tallarigo C. Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (1982–1997).  Urology. 2000;  56 58-62
    CrossrefPubMedGoogle Scholar
  • 5 Janzen N K, Kim H L, Figlin R A et al.. Surveillance after radical or nephron sparing surgery for localized renal cell carcinoma and management of recurrent disease.  Urol Clin North Am. 2003;  30 843-852
    CrossrefPubMedGoogle Scholar
  • 6 Fergany A F, Hafez K S, Novick A C. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year follow up.  J Urol. 2000;  163 442-445
    CrossrefPubMedGoogle Scholar
  • 7 Gill I S, Kavoussi L R, Lane B R et al.. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors.  J Urol. 2007;  178 41-46
    CrossrefPubMedGoogle Scholar
  • 8 Breda A, Finelli A, Janetschek G, Porpiglia F, Montorsi F. Complications of laparoscopic surgery for renal masses: prevention, management, and comparison with the open experience.  Eur Urol. 2009;  55 836-850
    CrossrefPubMedGoogle Scholar
  • 9 Spaliviero M, Moinzadeh A, Gill I S. Laparoscopic cryotherapy for renal tumors.  Technol Cancer Res Treat. 2004;  3 177-180
    PubMedGoogle Scholar
  • 10 Hui G C, Tuncali K, Tatli S, Morrison P R, Silverman S G. Comparison of percutaneous and surgical approaches to renal tumor ablation: metaanalysis of effectiveness and complication rates.  J Vasc Interv Radiol. 2008;  19 1311-1320
    CrossrefPubMedGoogle Scholar
  • 11 Gervais D A, McGovern F J, Wood B J et al.. Radiofrequency ablation of renal cell carcinoma: early clinical experience.  Radiology. 2000;  217 665-672
    CrossrefPubMedGoogle Scholar
  • 12 Atwell T D, Farrell M A, Leibovich B C et al.. Percutaneous renal cryoablation: experience treating 115 tumors.  J Urol. 2008;  179 2136-2141
    CrossrefPubMedGoogle Scholar
  • 13 Maybody M, Solomon S B. Image-guided percutaneous cryoablation of renal tumors.  Tech Vasc Interv Radiol. 2007;  10 140-148
    CrossrefPubMedGoogle Scholar
  • 14 Boss A, Clasen S, Kuczyk M et al.. Magnetic resonance-guided percutaneous radiofrequency ablation of renal cell carcinomas: a pilot clinical study.  Invest Radiol. 2005;  40 583-590
    CrossrefPubMedGoogle Scholar
  • 15 Miki K, Shimomura T, Yamada H et al.. Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging.  Int J Urol. 2006;  13 880-884
    CrossrefPubMedGoogle Scholar
  • 16 Farrell M A, Charboneau J W, Callstrom M R et al.. Paranephric water instillation: a technique to prevent bowel injury during percutaneous renal radiofrequency ablation.  AJR Am J Roentgenol. 2003;  181 1315-1317
    PubMedGoogle Scholar
  • 17 Kam A W, Littrup P J, Walther M M et al.. Thermal protection during percutaneous thermal ablation of renal cell carcinoma.  J Vasc Interv Radiol. 2004;  15 753-758
    CrossrefPubMedGoogle Scholar
  • 18 Gervais D A, Arellano R S, McGovern F J, McDougal W S, Mueller P R. Radiofrequency ablation of renal cell carcinoma: part 2, lessons learned with ablation of 100 tumors.  AJR Am J Roentgenol. 2005;  185 72-80
    CrossrefPubMedGoogle Scholar
  • 19 Cantwell C P, Wah T M, Gervais D A et al.. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water.  J Vasc Interv Radiol. 2008;  19 1034-1040
    CrossrefPubMedGoogle Scholar
  • 20 Park B K, Kim C K. Using an electrode as a lever to increase the distance between renal cell carcinoma and bowel during CT-guided radiofrequency ablation.  Eur Radiol. 2008;  18 743-746
    CrossrefPubMedGoogle Scholar
  • 21 Allaf M E, Varkarakis I M, Bhayani S B et al.. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation – initial observations.  Radiology. 2005;  237 366-370
    CrossrefPubMedGoogle Scholar
  • 22 Littrup P J, Ahmed A, Aoun H D et al.. CT-guided percutaneous cryotherapy of renal masses.  J Vasc Interv Radiol. 2007;  18 383-392
    CrossrefPubMedGoogle Scholar
  • 23 Solomon S B, Chan D Y, Jarrett T W. Percutaneous cryotherapy of kidney tumors.  Am J Urol Rev. 2004;  2 369-371
    PubMedGoogle Scholar
  • 24 Silverman S G, Tuncali K, van Sonnenberg E et al.. Renal tumors MR imaging-guided percutaneous cryotherapy – initial experience in 23 patients.  Radiology. 2005;  236 716-724
    CrossrefPubMedGoogle Scholar
  • 25 Gill I S, Novick A C, Meraney A M et al.. Laparoscopic renal cryoablation in 32 patients.  Urology. 2000;  56 748-753
    CrossrefPubMedGoogle Scholar
  • 26 Matin S F, Ahrar K, Cadeddu J A et al.. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study.  J Urol. 2006;  176 1973-1977
    CrossrefPubMedGoogle Scholar
  • 27 Permpongkosol S, Nicol T L, Link R E et al.. Differences in ablation size in porcine kidney, liver, and lung after cryoablation using the same ablation protocol.  AJR Am J Roentgenol. 2007;  188 1028-1032
    CrossrefPubMedGoogle Scholar
  • 28 Gervais D A, McGovern F J, Arellano R S, McDougal W S, Mueller P R. Radiofrequency ablation of renal cell carcinoma. Part 1. Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors.  AJR Am J Roentgenol. 2005;  185 64-71
    CrossrefPubMedGoogle Scholar
  • 29 McDougal W S, Gervais D A, McGovern F J, Mueller P R. Long-term follow-up of patients with renal cell carcinoma treated with radio frequency ablation with curative intent.  J Urol. 2005;  174 61-63
    CrossrefPubMedGoogle Scholar
  • 30 Simon C J, Dupuy D E, Mayo-Smith W W. Microwave ablation: principles and applications.  Radiographics. 2005;  25 S69-S83
    CrossrefPubMedGoogle Scholar
  • 31 Dick E A, Joarder R, De Jode M G, Wragg P, Vale J A, Gedroyc W M. Magnetic resonance imaging-guided laser thermal ablation of renal tumours.  BJU Int. 2002;  90(9) 814-822
    CrossrefPubMedGoogle Scholar
  • 32 Rubinsky B, Onik G, Mikus P. Irreversible electroporation: a new ablation modality: clinical implications.  Technol Cancer Res Treat. 2007;  6 37-48
    CrossrefPubMedGoogle Scholar
  • 33 Marberger M, Schatzl G, Kranston D, Kennedy J E. Extracorporeal ablation of renal tumors with high intensity focused ultrasound.  BJU Int. 2005;  95 52-55
    CrossrefPubMedGoogle Scholar
  • 34 Klatte T, Marberger M. High-intensity focused ultrasound for the treatment of renal masses: current status and future potential.  Curr Opin Urol. 2009;  19 188-191
    CrossrefPubMedGoogle Scholar
  • 35 Johnson D B, Solomon S B, Su L M et al.. Defining the complications of cryoablation and radiofrequency ablation of small renal tumors: a multi-institutional review.  J Urol. 2004;  172 874-877
    CrossrefPubMedGoogle Scholar
  • 36 Smith S, Gillams A. Imaging appearances following thermal ablation.  Clin Radiol. 2008;  63 1-11
    CrossrefPubMedGoogle Scholar
  • 37 Merkle E M, Nour S G, Lewin J S. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months.  Radiology. 2005;  235 1065-1071
    CrossrefPubMedGoogle Scholar
  • 38 Uppot R N, Silverman S G, Zagoria R J, Tuncali K, Childs D D, Gervais D A. Imaging-guided percutaneous ablation of renal cell carcinoma: a primer of how we do it.  AJR Am J Roentgenol. 2009;  192 1558-1570
    CrossrefPubMedGoogle Scholar
  • 39 Kawamoto S, Solomon S B, Bluemke D A, Fishman E K. Computed tomography and magnetic resonance imaging appearance of renal neoplasms after radiofrequency ablation and cryoablation.  Semin Ultrasound CT MR. 2009;  30 67-77
    CrossrefPubMedGoogle Scholar
  • 40 Gill I S, Remer E M, Hasan W A et al.. Renal cryoablation: outcome at 3 years.  J Urol. 2005;  173 1903-1907
    CrossrefPubMedGoogle Scholar
  • 41 Janzen N K, Perry K T, Han K R et al.. The effects of intentional cryoablation and radiofrequency ablation of renal tissue involving the collecting system in a porcine model.  J Urol. 2005;  173 1368-1374
    CrossrefPubMedGoogle Scholar

Majid MaybodyM.D. 

Section of Interventional Radiology, Department of Radiology, Memorial Sloan-Kettering Cancer Center

1275 York Avenue, H118A New York, NY 10065

eMail: maybodym@mskcc.org